X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.

In February 2005, a 23-year-old Burmese man checked into a rural hospital in East Burma with a fairly ordinary case of malaria. The hospital gave him the usual treatment — artesunate pills, a medicine heralded as a miracle cure for its speed in treating the disease. Three days later, he slipped into a coma. Within 12 hours, the man was dead. The miracle drug had failed — or so it seemed. The hospital’s entire stock of artesunate was counterfeit, investigation later showed. The pills, which looked like legitimate artesunate made by Chinese company Guilin Pharmaceutical Co. contained only 20 percent of the necessary active ingredient. Death brought the Burmese man a kind of fame — his was the first confirmed death directly linked to counterfeit antimalarials.

This content has been archived. It is available exclusively through our partner LexisNexis®.

To view this content, please continue to Lexis Advance®.

Not a Lexis Advance® Subscriber? Subscribe Now

Why am I seeing this?

LexisNexis® is now the exclusive third party online distributor of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® customers will be able to access and use ALM's content by subscribing to the LexisNexis® services via Lexis Advance®. This includes content from the National Law Journal®, The American Lawyer®, Law Technology News®, The New York Law Journal® and Corporate Counsel®, as well as ALM's other newspapers, directories, legal treatises, published and unpublished court opinions, and other sources of legal information.

ALM's content plays a significant role in your work and research, and now through this alliance LexisNexis® will bring you access to an even more comprehensive collection of legal content.

For questions call 1-877-256-2472 or contact us at customercare@alm.com

 
 

ALM Legal Publication Newsletters

Sign Up Today and Never Miss Another Story.

As part of your digital membership, you can sign up for an unlimited number of a wide range of complimentary newsletters. Visit your My Account page to make your selections. Get the timely legal news and critical analysis you cannot afford to miss. Tailored just for you. In your inbox. Every day.

Copyright © 2020 ALM Media Properties, LLC. All Rights Reserved.